Fig. 4: Cost-effectiveness of different screening schedules on identifying SARS-CoV-2 infected individuals under baseline setting (Re = 2.0, p= 0.7). | Communications Medicine

Fig. 4: Cost-effectiveness of different screening schedules on identifying SARS-CoV-2 infected individuals under baseline setting (Re = 2.0, p= 0.7).

From: A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks

Fig. 4

a. Number of used antigen tests for identifying SARS-CoV-2 infected individuals under different screening schedules. b. Number of used antigen tests for identifying SARS-CoV-2 symptomatic individuals before being identified by antigen tests under different screening schedules. c. Incremental cost-effectiveness ratio (ICER) of different screening schedules compared to Schedule 0. We used baseline values for screening programs (i.e., low sensitivity tests [\(2.0\times {10}^{6}\) copies/mL], screening initiation at peak phase, and 4 antigen tests for each person).

Back to article page